Ritlecitinib for keloid treatment and prevention
Treatments studied
Part of Skin clinical trials.
This trial tests if ritlecitinib, an oral medication, can treat existing keloids (raised scars that grow beyond the original wound) or prevent new ones from forming after surgical removal. It may help people with large or painful keloids that haven't responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 50 years old (no more than 10% of participants can be over 50).
- You have at least one keloid that is 2 cm or larger on your earlobe, or 3 cm or larger elsewhere, and it hasn't improved with treatments like steroid injections or creams.
- You are willing to have surgery to remove the keloid (Group 1) OR you choose not to have surgery but have a painful or itchy keloid (Group 2).
- You can take oral medication and are in generally good health without serious uncontrolled conditions.
- If you are a woman who could become pregnant, you must use effective birth control during and for 28 days after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how radiation (RT) can treat keloids, especially when surgery is not possible or you choose not to do surgery. The goal is to see if radiation can safely improve or control the keloid.
This study compares freezing treatments (cryosurgery) alone versus combining freezing with two injectable medications (5-FU and triamcinolone) to treat keloids — raised, thick scars that can be painful or itchy. The goal is to see which approach works better for flattening and improving the scar.
This trial provides early access to an investigational drug called ritlecitinib for people with severe alopecia areata who have not responded to other treatments. It aims to help regrow hair by targeting the immune system.
This study tests two different doses of a pill called ritlecitinib to see if it can help regrow hair in people with significant hair loss from alopecia areata. It is for people aged 12 and older who have lost at least half of their scalp hair.
This trial tests a new microneedle patch that may help reduce keloid scars on the ear after surgery. The patch contains a special material (siRNA) that can affect scar tissue, and it is applied directly to the scar.
This study tests a medicine called ritlecitinib for children with severe alopecia areata (a condition causing hair loss). It is for kids who have already completed a previous study of this medicine to see how well it works and how safe it is over a longer period.
Hear when a new Keloid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.